BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21712736)

  • 1. Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.
    Sai AJ; Gallagher JC; Fang X
    Menopause; 2011 Oct; 18(10):1101-12. PubMed ID: 21712736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
    Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.
    Lindheim SR; Notelovitz M; Feldman EB; Larsen S; Khan FY; Lobo RA
    Obstet Gynecol; 1994 Feb; 83(2):167-72. PubMed ID: 8290176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
    Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.
    Lamon-Fava S; Asztalos BF; Howard TD; Reboussin DM; Horvath KV; Schaefer EJ; Herrington DM
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):169-75. PubMed ID: 19489872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein compositional changes with combination hormone therapy (conjugated estrogen and medroxyprogesterone) in African American women.
    Hughes TA; Pace DT; Ke RW; Tolley EA; Qureshi N; Stentz F
    Endocr Pract; 2004; 10(3):179-86. PubMed ID: 15310534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
    Gomes-Rochette NF; Souza LS; Tommasi BO; Pedrosa DF; Eis SR; Fin ID; Vieira FL; Graceli JB; Rangel LB; Silva IV
    PLoS One; 2017; 12(2):e0169266. PubMed ID: 28199328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy.
    Nogueira-de-Souza NC; Guerreiro da Silva ID; Carvalho CV; Pulchinelli A; Haidar MA; Baracat EC; Massad-Costa AM
    Braz J Med Biol Res; 2009 Dec; 42(12):1138-42. PubMed ID: 19936541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
    JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women.
    Binder EF; Birge SJ; Kohrt WM
    J Am Geriatr Soc; 1996 Mar; 44(3):231-6. PubMed ID: 8600189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms.
    Yalamanchili V; Gallagher JC
    Menopause; 2012 Jun; 19(6):697-703. PubMed ID: 22205149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
    JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.